Journal article

Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine.

Matthew M Davis, Serigne M Ndiaye, Gary L Freed, Christopher S Kim, Sarah J Clark

Pediatrics | Published : 2003


OBJECTIVE: In 2000, heptavalent pneumococcal conjugate vaccine (PCV7) was recommended for children younger than 2 years, but its high cost relative to other universally recommended childhood immunizations and variability in insurance coverage for the vaccine raised concerns. We investigated the influence of PCV7 cost and insurance coverage on physician recommendation of PCV7 to their patients and administration of PCV7 in their practices. METHODS: We conducted a mail survey from April to July 2001 of a random sample of 833 pediatricians and 788 family physicians in 24 states with different vaccine financing strategies (Vaccines for Children [VFC]-only; enhanced VFC; universal purchase). Phys..

View full abstract